• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈萨克斯坦拉丁美洲-地中海分枝杆菌临床株系的基因组分析。

Genomic analysis of Latin American-Mediterranean family of Mycobacterium tuberculosis clinical strains from Kazakhstan.

机构信息

National Center for Biotechnology, Nur-Sultan, Kazakhstan.

National Scientific Center for Phthisiopulmonology, Almaty, Kazakhstan.

出版信息

Mem Inst Oswaldo Cruz. 2020 Sep 18;115:e200215. doi: 10.1590/0074-02760200215. eCollection 2020.

DOI:10.1590/0074-02760200215
PMID:32965331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7508292/
Abstract

The human-adapted strains of the Mycobacterium tuberculosis complex (MTBC) comprise seven phylogenetic lineages originally associated with their geographical distribution. Here, we report the genomes of three drug-resistant clinical isolates of the Latin American-Mediterranean (LAM) family collected in Kazakhstan. We utilised whole-genome sequencing to study the distribution and drug resistance of these isolates. Phylogenetic analysis grouped the genomes described in this study with the sequences from Russia, Uzbekistan, and Kazakhstan belonging to the LAM family. One isolate has acquired extensive drug resistance to seven antituberculosis drugs. Our results suggest at least two multi-drug resistant (MDR)/extensively drug-resistant (XDR)-associated genotypes of the LAM family circulate in Kazakhstan.

摘要

人类适应的结核分枝杆菌复合群(MTBC)菌株包括最初与其地理分布相关的七个系统发育谱系。在这里,我们报告了在哈萨克斯坦收集的三种抗药性临床分离株的基因组,这些分离株属于拉丁美洲-地中海(LAM)家族。我们利用全基因组测序来研究这些分离株的分布和耐药性。系统发育分析将本研究中描述的基因组与来自俄罗斯、乌兹别克斯坦和哈萨克斯坦的 LAM 家族序列进行了分组。一个分离株对七种抗结核药物产生了广泛的耐药性。我们的结果表明,哈萨克斯坦至少存在两种流行的 LAM 家族的耐多药/广泛耐药(MDR/XDR)相关基因型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069e/7508292/daae81c4683a/1678-8060-mioc-115-e200215-gf.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069e/7508292/daae81c4683a/1678-8060-mioc-115-e200215-gf.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/069e/7508292/daae81c4683a/1678-8060-mioc-115-e200215-gf.jpg

相似文献

1
Genomic analysis of Latin American-Mediterranean family of Mycobacterium tuberculosis clinical strains from Kazakhstan.哈萨克斯坦拉丁美洲-地中海分枝杆菌临床株系的基因组分析。
Mem Inst Oswaldo Cruz. 2020 Sep 18;115:e200215. doi: 10.1590/0074-02760200215. eCollection 2020.
2
Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94-32 central Asian/Russian clusters.高通量方法组合对哈萨克斯坦耐多药/广泛耐药结核的基因组特征分析表明,L2/Beijing 94-32 中亚/俄罗斯聚类持续传播。
BMC Infect Dis. 2019 Jun 24;19(1):553. doi: 10.1186/s12879-019-4201-2.
3
Molecular snapshot of Mycobacterium tuberculosis population in Kazakhstan: a country-wide study.哈萨克斯坦结核分枝杆菌种群的分子快照:一项全国性研究。
Tuberculosis (Edinb). 2015 Sep;95(5):538-46. doi: 10.1016/j.tube.2015.04.012. Epub 2015 May 14.
4
Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from Russia.俄罗斯结核分枝杆菌耐药株的比较基因组分析。
PLoS One. 2013;8(2):e56577. doi: 10.1371/journal.pone.0056577. Epub 2013 Feb 20.
5
Trends in molecular epidemiology of drug-resistant tuberculosis in Republic of Karelia, Russian Federation.俄罗斯联邦卡累利阿共和国耐药结核病的分子流行病学趋势
BMC Microbiol. 2015 Dec 18;15:279. doi: 10.1186/s12866-015-0613-3.
6
Diversified lineages and drug-resistance profiles of clinical isolates of complex in Malaysia.马来西亚复杂临床分离株的多样化谱系和耐药性特征。
Int J Mycobacteriol. 2019 Oct-Dec;8(4):320-328. doi: 10.4103/ijmy.ijmy_144_19.
7
The Impact of the Mycobacterium tuberculosis RDRio Subfamily on Multidrug-Resistant Tuberculosis in Latin America: A Comprehensive Review.结核分枝杆菌 RDRio 亚家族对拉丁美洲耐多药结核病的影响:综合评价。
Am J Trop Med Hyg. 2024 Jul 2;111(2):230-236. doi: 10.4269/ajtmh.24-0073. Print 2024 Aug 7.
8
Molecular structure of Mycobacterium tuberculosis population in Russia and its interaction with neighboring countries.俄罗斯结核分枝杆菌种群的分子结构及其与邻国的相互作用。
Int J Mycobacteriol. 2015 Mar;4 Suppl 1:56-7. doi: 10.1016/j.ijmyco.2014.08.002. Epub 2014 Sep 3.
9
Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.葡萄牙开展分枝杆菌间隔重复单位分型和耐多药及广泛耐药结核监测的突变特征:3 年期间概述。
Int J Antimicrob Agents. 2014 Dec;44(6):546-51. doi: 10.1016/j.ijantimicag.2014.06.021. Epub 2014 Sep 6.
10
Multidrug-Resistant Mycobacterium tuberculosis of the Latin American Mediterranean Lineage, Wrongly Identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), Causing Active Tuberculosis in South Brazil.拉丁美洲地中海谱系的耐多药结核分枝杆菌,被错误鉴定为海豹分枝杆菌(国际分型863 [SIT863]),在巴西南部引起活动性结核病。
J Clin Microbiol. 2015 Dec;53(12):3805-11. doi: 10.1128/JCM.02012-15.

引用本文的文献

1
Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant in Kazakhstan.哈萨克斯坦耐多药结核病患者中北京中亚/俄罗斯94-32簇的流行情况。
Antibiotics (Basel). 2023 Dec 20;13(1):9. doi: 10.3390/antibiotics13010009.
2
Draft genome sequence of a multidrug-resistant clinical isolate, 3184-KZ.多重耐药临床分离株3184-KZ的基因组序列草图
Microbiol Resour Announc. 2023 Dec 14;12(12):e0086323. doi: 10.1128/MRA.00863-23. Epub 2023 Nov 15.
3
Genomic Characterization of Drug-Resistant L2/Beijing Isolates from Astana, Kazakhstan.

本文引用的文献

1
Frequency of the Mycobacterium tuberculosis RD genotype and its association with multidrug-resistant tuberculosis.结核分枝杆菌 RD 基因型的频率及其与耐多药结核病的关系。
BMC Infect Dis. 2019 Jun 25;19(1):556. doi: 10.1186/s12879-019-4152-7.
2
Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94-32 central Asian/Russian clusters.高通量方法组合对哈萨克斯坦耐多药/广泛耐药结核的基因组特征分析表明,L2/Beijing 94-32 中亚/俄罗斯聚类持续传播。
BMC Infect Dis. 2019 Jun 24;19(1):553. doi: 10.1186/s12879-019-4201-2.
3
来自哈萨克斯坦阿斯塔纳的耐多药L2/北京基因型菌株的基因组特征分析
Antibiotics (Basel). 2023 Oct 10;12(10):1523. doi: 10.3390/antibiotics12101523.
4
Whole-Genome Sequence-Based Characterization of Pre-XDR Clinical Isolates Collected in Kazakhstan.基于全基因组序列对哈萨克斯坦收集的准广泛耐药临床分离株的特征分析。
Diagnostics (Basel). 2023 Jun 8;13(12):2005. doi: 10.3390/diagnostics13122005.
Mycobacterium tuberculosis RD-Rio Strain in Kazakhstan.
哈萨克斯坦的结核分枝杆菌 RD-Rio 株。
Emerg Infect Dis. 2019 Mar;25(3):604-606. doi: 10.3201/eid2503.181179.
4
Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia.补偿进化导致中亚地区耐多药结核病。
Elife. 2018 Oct 30;7:e38200. doi: 10.7554/eLife.38200.
5
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.基于 DNA 测序的一线抗结核药物敏感性预测。
N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.
6
On sunspots, click science and molecular iconography.在太阳黑子上,点击科学与分子图像。
Tuberculosis (Edinb). 2018 May;110:91-95. doi: 10.1016/j.tube.2018.04.004. Epub 2018 Apr 10.
7
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.结核分枝杆菌4型包括全球分布和地理上受限的亚分支。
Nat Genet. 2016 Dec;48(12):1535-1543. doi: 10.1038/ng.3704. Epub 2016 Oct 31.
8
Molecular Strain Typing of Mycobacterium tuberculosis: a Review of Frequently Used Methods.结核分枝杆菌的分子菌株分型:常用方法综述
J Korean Med Sci. 2016 Nov;31(11):1673-1683. doi: 10.3346/jkms.2016.31.11.1673.
9
NCBI prokaryotic genome annotation pipeline.美国国立生物技术信息中心原核生物基因组注释管道
Nucleic Acids Res. 2016 Aug 19;44(14):6614-24. doi: 10.1093/nar/gkw569. Epub 2016 Jun 24.
10
Latin-American-Mediterranean lineage of Mycobacterium tuberculosis: Human traces across pathogen's phylogeography.结核分枝杆菌的拉丁美洲-地中海谱系:病原体系统地理学中的人类踪迹
Mol Phylogenet Evol. 2016 Jun;99:133-143. doi: 10.1016/j.ympev.2016.03.020. Epub 2016 Mar 19.